Baillie Gifford & Co’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,487
| Closed | -$65K | – | 511 |
|
|
2022
Q1 | $65K | Hold |
5,487
| – | – | ﹤0.01% | 299 |
|
|
2021
Q4 | $101K | Hold |
5,487
| – | – | ﹤0.01% | 297 |
|
|
2021
Q3 | $138K | Hold |
5,487
| – | – | ﹤0.01% | 280 |
|
|
2021
Q2 | $347K | Hold |
5,487
| – | – | ﹤0.01% | 272 |
|
|
2021
Q1 | $676K | Hold |
5,487
| – | – | ﹤0.01% | 264 |
|
|
2020
Q4 | $624K | Hold |
5,487
| – | – | ﹤0.01% | 254 |
|
|
2020
Q3 | $655K | Hold |
5,487
| – | – | ﹤0.01% | 244 |
|
|
2020
Q2 | $683K | Buy |
5,487
+3,682
| +204% | +$458K | ﹤0.01% | 227 |
|
|
2020
Q1 | $349K | Buy |
+1,805
| New | +$349K | ﹤0.01% | 210 |
|